| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals, Inc. (ARWR) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. ARWR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $311.00M | - | |
| COO | 473.3K | $38.81M | - | |
| Other | 227.0K | $18.61M | - | |
| CFO | 162.9K | $13.36M | - | |
| Dir | 123.1K | $10.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2019 | Given Bruce D | Chief Operating Officer | Sell | 20,000 | $11.98 | $239,600.00 | -1.8% | |
| Dec 27, 2018 | Given Douglas B66 | Director | Sell | 3,000 | $12.00 | $36,000.00 | -2.0% | |
| Dec 19, 2018 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 90,000 | $13.92 | $1,252,800.00 | -5.5% | |
| Dec 12, 2018 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 90,000 | $14.07 | $1,266,300.00 | -5.2% | |
| Nov 23, 2018 | Given Douglas B66 | Director | Sell | 3,000 | $12.74 | $38,220.00 | -2.0% | |
| Nov 9, 2018 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 81,500 | $14.39 | $1,172,705.00 | -2.3% | |
| Oct 19, 2018 | Leone Peter Brian | VP, Strategic Bus. Initiatives | Sale+OE | 131,137 | $13.49 | $1,769,038.13 | -50.2% | |
| Sep 6, 2018 | Myszkowski Kenneth Allen68 | Chief Financial Officer | Sale+OE | 45,000 | $19.34 | $870,200.00 | -6.6% | |
| Sep 4, 2018 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 164,834 | $14.45 | $2,381,851.30 | -4.3% | |
| Jun 19, 2018 | Myszkowski Kenneth Allen68 | Chief Financial Officer | Sale+OE | 20,000 | $14.01 | $280,200.00 | -6.0% |